These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38942574)

  • 1. Erratum to: Baty M, Pasquier D, Gnep K, et al. Achievable Dosimetric Constraints in Stereotactic Reirradiation for Recurrent Prostate Cancer. Pract Radiat Oncol. 2023;13:e515-e529.
    Pract Radiat Oncol; 2024; 14(4):360. PubMed ID: 38942574
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum to: Booth V, Eade T, Hruby G, et al. Decision Regret and Bother With the Addition of Androgen Deprivation Therapy to Definitive Radiation Treatment for Localized Prostate Cancer. Pract Radiat Oncol. 2023;13:e400-e408.
    Pract Radiat Oncol; 2024; 14(2):171. PubMed ID: 38431367
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum to: Katsoulakis E, Kudner R, Chapman C, et al. Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. Pract Radiat Oncol. 2022; 12(5):409-423.
    Pract Radiat Oncol; 2023; 13(5):e460-e469. PubMed ID: 37652624
    [No Abstract]   [Full Text] [Related]  

  • 4. Erratum to: Chuong MD, Bryant J, Mittauer KE, Hall M, Kotecha R, Alvarez D, Romaguera T, Rubens M, Adamson S, Godley A, Mishra V, Luciani G, Gutierrez AN. Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer. Pract Radiat Oncol. 2021;11:134-147.
    Pract Radiat Oncol; 2021; 11(3):e354. PubMed ID: 33941354
    [No Abstract]   [Full Text] [Related]  

  • 5. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer: in regard to Roh et Al (Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1348-55.
    Yazici G; Cengiz M; Akyol F
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1278; author reply 1278. PubMed ID: 20206031
    [No Abstract]   [Full Text] [Related]  

  • 6. Erratum to: Worrell SG, Goodman KA, Altorki NK, et al. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Pract Radiat Oncol. 2024;14:28-46.
    Pract Radiat Oncol; 2024; 14(2):172. PubMed ID: 38185278
    [No Abstract]   [Full Text] [Related]  

  • 7. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer: in regard to Unger et al. (Int J Radiat Oncol Biol Phys 2010;77:1411-1419).
    Rwigema JC; Heron DE
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1323; author reply 1323-4. PubMed ID: 22385722
    [No Abstract]   [Full Text] [Related]  

  • 8. Using Bayesian logistic regression to evaluate a new type of dosimetric constraint for prostate radiotherapy treatment planning.
    Buettner F; Gulliford SL; Webb S; Partridge M
    Med Phys; 2010 Apr; 37(4):1768-77. PubMed ID: 20443499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum to: Park J, Venkatesulu BP, Kujundzic K, Katsoulakis E, Solanki AA, Puckett LL, Kapoor R, Chapman CH, Hagan M, Kelly MD, Palta J, Ashman JB, Jacqmin D, Kachnic LA, Minsky BD, Olsen J, Raldow AC, Wo JY, Dawes S, Wilson E, Kudner R, Das P. Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. Pract Radiat Oncol 2022;12:424-436.
    Pract Radiat Oncol; 2023; 13(4):370-375. PubMed ID: 37391240
    [No Abstract]   [Full Text] [Related]  

  • 10. Erratum to: Wattson DA, Chen M-H, Moul JW, et al. The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: Implications for treatment selection. Int J Radiat Oncol Biol Phys 2012;82:e773-e779.
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):730. PubMed ID: 26461024
    [No Abstract]   [Full Text] [Related]  

  • 11. Achievable Dosimetric Constraints in Stereotactic Reirradiation for Recurrent Prostate Cancer.
    Baty M; Pasquier D; Gnep K; Castelli J; Delaby N; Lacornerie T; de Crevoisier R
    Pract Radiat Oncol; 2023; 13(6):e515-e529. PubMed ID: 37295723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum to "E.C. Lerner, E.S. Srinivasan, G. Broadwater, et al. Factors Associated With New-Onset Seizures Following Stereotactic Radiosurgery for Newly Diagnosed Brain Metastases. 
    Lerner EC; Srinivasan ES; Broadwater G; Haskell-Mendoza AP; Vaios EJ; Edwards RM; Wachsmuth LP; Huie D; Floyd SR; Adamson JD; Fecci PE
    Adv Radiat Oncol; 2023; 8(2):101187. PubMed ID: 37008273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum to: Jang JK, Reilly M, Yaghmour G, Rashid F, Ballas LK. Acute Respiratory Events and Dosimetry of Total Body Irradiation Patients Using in Vivo Lung Dose Monitoring and Custom Lung Block Adaptation. Pract Radiat Oncol 2020;10:e397-e405.
    Pract Radiat Oncol; 2021; 11(2):e245. PubMed ID: 33676633
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum to: Schreibmann E, Schuster D, Rossi P, et al. Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial. Int J Radiat Oncol Biol Phys 2016;96:206-213.
    Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):231. PubMed ID: 30102199
    [No Abstract]   [Full Text] [Related]  

  • 15. Erratum to: Wilkins AC, Gusterson B, Szijgyarto Z, et al. Ki67 Is an Independent Predictor of Recurrence in the Largest Randomized Trial of 3 Radiation Fractionation Schedules in Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2018;101:309-315.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967236
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol. Eur Urol Oncol. 2023;6:399-405.
    Grivas N; Zampaftis C; Ermidis D; Leotsakos I; Katafigiotis I; Karavitakis M
    Eur Urol Oncol; 2023 Dec; 6(6):640. PubMed ID: 37003860
    [No Abstract]   [Full Text] [Related]  

  • 17. Erratum to: Sanders JW, Venkatesan AM, Levitt CA, et al. Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study. Int J Radiat Oncol Biol Phys 2021;109(2):614-625.
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):238. PubMed ID: 35427557
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to: Iuchi T, Hatano K, Uchino Y, et al. Methionine uptake and required radiation dose to control glioblastoma. Int J Radiat Oncol Biol Phys 2015;93:133-140.
    Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):215. PubMed ID: 29611531
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum: Marks LB, Jackson M, Xie L, et al. The challenge of maximizing safety in radiation oncology. Practical Radiat Oncol. 2011;1:2-14.
    Pract Radiat Oncol; 2011; 1(2):140. PubMed ID: 24673929
    [No Abstract]   [Full Text] [Related]  

  • 20. 4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U/S-based prostate HDR brachytherapy treatment delivery.
    Milickovic N; Mavroidis P; Tselis N; Nikolova I; Katsilieri Z; Kefala V; Zamboglou N; Baltas D
    Med Phys; 2011 Sep; 38(9):4982-93. PubMed ID: 21978042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.